| David Martin Bell, DO | |
|
6116 E Arbor Ave, Suite 112, Mesa, AZ 85206-6107 | |
| (480) 641-5400 | |
| (480) 218-4353 |
| Full Name | David Martin Bell |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 25 Years |
| Location | 6116 E Arbor Ave, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518060938 | NPI | - | NPPES |
| 167297 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 4428 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Ironwood Medical Center | Queen creek, AZ | Hospital |
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Banner Goldfield Medical Center | Apache junction, AZ | Hospital |
| Banner Heart Hospital | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiovascular Associates Of Mesa Pc | 3779479357 | 10 |
News Archive
Some of the 26 million Americans with asthma may also be prone to bone loss. According to a study published today in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology, there seems to be association between asthma and a decrease in bone mineral density.
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office (USPTO) has allowed an Isis patent application that further expands the scope of the "Crooke" patent estate. The newly allowed patent broadly covers methods of cleaving a target RNA via a double-stranded ribonuclease mechanism, including the RNAi mechanism, with chemically modified, single-stranded RNA-containing drugs.
Northstar Healthcare Inc. today announced that it plans to complete a non-brokered private placement of common shares to Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
GlaxoSmithKline announced today that the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has released the first lots of FluLaval® [Influenza Virus Vaccine] allowing distribution in the U.S. to begin for the 2010-2011 flu season. GSK anticipates distribution of Fluarix® [Influenza Virus Vaccine] to follow in the next several weeks.
New research has found that adolescents with higher levels of an omega-3 fatty acid in their blood were less likely to develop psychotic disorder in early adulthood, suggesting that it may have a potential preventative effect of reducing the risk of psychosis.
› Verified 9 days ago
| Entity Name | Cardiovascular Associates Of Mesa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104815158 PECOS PAC ID: 3779479357 Enrollment ID: O20040223000639 |
News Archive
Some of the 26 million Americans with asthma may also be prone to bone loss. According to a study published today in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology, there seems to be association between asthma and a decrease in bone mineral density.
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office (USPTO) has allowed an Isis patent application that further expands the scope of the "Crooke" patent estate. The newly allowed patent broadly covers methods of cleaving a target RNA via a double-stranded ribonuclease mechanism, including the RNAi mechanism, with chemically modified, single-stranded RNA-containing drugs.
Northstar Healthcare Inc. today announced that it plans to complete a non-brokered private placement of common shares to Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
GlaxoSmithKline announced today that the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has released the first lots of FluLaval® [Influenza Virus Vaccine] allowing distribution in the U.S. to begin for the 2010-2011 flu season. GSK anticipates distribution of Fluarix® [Influenza Virus Vaccine] to follow in the next several weeks.
New research has found that adolescents with higher levels of an omega-3 fatty acid in their blood were less likely to develop psychotic disorder in early adulthood, suggesting that it may have a potential preventative effect of reducing the risk of psychosis.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Martin Bell, DO 6116 E Arbor Ave, Suite 112, Mesa, AZ 85206-6107 Ph: (480) 641-5400 | David Martin Bell, DO 6116 E Arbor Ave, Suite 112, Mesa, AZ 85206-6107 Ph: (480) 641-5400 |
News Archive
Some of the 26 million Americans with asthma may also be prone to bone loss. According to a study published today in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology, there seems to be association between asthma and a decrease in bone mineral density.
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office (USPTO) has allowed an Isis patent application that further expands the scope of the "Crooke" patent estate. The newly allowed patent broadly covers methods of cleaving a target RNA via a double-stranded ribonuclease mechanism, including the RNAi mechanism, with chemically modified, single-stranded RNA-containing drugs.
Northstar Healthcare Inc. today announced that it plans to complete a non-brokered private placement of common shares to Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
GlaxoSmithKline announced today that the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has released the first lots of FluLaval® [Influenza Virus Vaccine] allowing distribution in the U.S. to begin for the 2010-2011 flu season. GSK anticipates distribution of Fluarix® [Influenza Virus Vaccine] to follow in the next several weeks.
New research has found that adolescents with higher levels of an omega-3 fatty acid in their blood were less likely to develop psychotic disorder in early adulthood, suggesting that it may have a potential preventative effect of reducing the risk of psychosis.
› Verified 9 days ago
Dr. Emmanuel A Bayongan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-543-2034 Fax: 480-512-6089 | |
Dr. Sanjeev Gopal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd, 104-105, Mesa, AZ 85206 Phone: 602-802-8700 Fax: 602-802-8799 | |
Mouhsen H Alhakeem, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Road, Attn Amanda Gump/hospitalist, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Bindu Jayavelu, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 301 S Power Rd Ste 103, Mesa, AZ 85206 Phone: 480-325-7535 Fax: 480-325-7462 | |
Mr. Robert Bobek Arashahi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5652 E Baseline Rd, Mesa, AZ 85206 Phone: 480-477-7166 | |
Mr. Robert P Tully, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7525 E Broadway Rd, Ste 2, Mesa, AZ 85208 Phone: 480-981-9800 Fax: 480-985-9465 | |
Joshua D Cohen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6750 E Baywood Ave, 301, Mesa, AZ 85206 Phone: 480-835-6100 Fax: 480-461-4261 |